Olaplex Holdings, Inc. OLPX 深 沪
已收盘 02-06 16:00:00 美东时间
1.50
0.000
0.00%
华盛通- 最 高1.536
- 今 开1.50
- 成交量 96.56万股
- 最 低 1.49
- 昨 收 1.50
- 总市值 10.01亿
- 52周最高 1.8387
- 市盈率 静 51.19
- 换手率 0.14%
- 52周最低 0.9923
- 委 比 -49.40%
- 总股本 6.68亿
- 历史最高 30.41
- 量 比 0.73
- 振 幅 3.07%
- 历史最低 0.9923
- 每 手 1
- 风险率 0.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多'Olaplex Is Said to Attract Takeover Offer From Germany's Henkel' - Bloomberg
https://www.bloomberg.com/news/articles/2026-01-07/olaplex-is-said-to-attract-takeover-offer-from-germany-s-henkel
01-08 03:33
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
2025-11-11 10:49
Barclays Maintains Equal-Weight on Olaplex Hldgs, Lowers Price Target to $1.25
Barclays analyst Lauren Lieberman maintains Olaplex Hldgs (NASDAQ:OLPX) with a Equal-Weight and lowers the price target from $1.5 to $1.25.
2025-11-11 02:53
Olaplex Hldgs Affirms FY2025 Sales Guidance of $410.000M-$431.000M vs $422.406M Est
Olaplex Hldgs (NASDAQ:OLPX) affirms FY2025 sales outlook from $410.000 million-$431.000 million to $410.000 million-$431.000 million vs $422.406 million estimate.
2025-11-06 19:47
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
2025-11-03 20:20
Telsey Advisory Group Maintains Market Perform on Olaplex Hldgs, Maintains $2 Price Target
Telsey Advisory Group analyst Dana Telsey maintains Olaplex Hldgs (NASDAQ:OLPX) with a Market Perform and maintains $2 price target.
2025-10-31 19:16
Olaplex Acquires Purvala Bioscience, Tapping MIT-Backed Biotech for Next-Gen Beauty and Health Solutions
Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or the "Company") today announced the acquisition of Purvala Bioscience, a Boston-based biotech company. This marks the first acquisition from OLAPLEX since the brand
2025-08-26 18:57
OLAPLEX Acquires Biotech Company Purvala
OLAPLEX, a leader in haircare innovation, announces its first acquisition since launching over ten years ago – the purchase of Purvala Bioscience, a Boston-based biotech company. Founded by MIT professors, Purvala specializes in bioinspired technologies for health and beauty. OLAPLEX CEO Amanda Baldwin highlights the merger as a step toward creating cutting-edge, science-backed products alongside their patented bond-building technology. The acqui...
2025-08-26 10:55
Canaccord Genuity Upgrades Olaplex Hldgs to Buy, Raises Price Target to $2
Canaccord Genuity analyst Susan Anderson upgrades Olaplex Hldgs (NASDAQ:OLPX) from Hold to Buy and raises the price target from $1.5 to $2.
2025-08-25 19:00
